China

The move adds to the company's further expansion of global network in the Asia Pacific region

Seventy new drugs such as Roche's breast cancer treatment Pertuzumab, sold under the trade name Perjeta, Novartis's dermatitis…

The office was established to provide regional marketing and pre-sales service to biotech, pharma and academic customers in China…

As opportunities in developed markets saturate, India Pharma Inc is looking to optimise the growth potential in China. But what…

The programme, rolled out last year, saw 11 Chinese cities, including Beijing and Shanghai, band together behind a tender process…

In the near term, the pharmaceutical company would continue to be driven by markets like India, Brazil and Canada

The Chinese pharma market is set to be worth $209 billion by 2022 Indian pharmaceutical companies are finding lucrative…

In May this year, KDPMA signed an MoU with SHENGJIE, a business management and consulting firm from China

According to the agreement, the joint venture company will now become a subsidiary of Cipla

There are plans to revive two old plants and steps have already been initiated Terming the import of large quantities of…